Sky Century Investment (SKYI) Net Cash Flow Growth (1y) (2013 - 2026)

Sky Century Investment (SKYI) Net Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 112.26%
3 Zoetis 32.51 Bn 30.57 Bn 1.62 Bn -44.11%
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 209.30%
5 United Therapeutics 23.18 Bn 21.03 Bn 648.10 Mn -236.85%
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 13,485.29%
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -1,047.81%
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -1,020.00%
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 -127.37%

Historic Data

Download Data
DateValue
May 31, 2026 -127.37%
Feb 28, 2014 -2,425.00%
Aug 31, 2013 107.84%